Operational assessments of Sayana® Press provision in Senegal and Uganda



      Sayana® Press (SP) is a unique injectable contraceptive (depot medroxyprogesterone acetate, or DMPA) administered subcutaneously in the UnijectTM injection system.
      Sayana Press and depo-subQ provera 104 in Uniject are registered trademarks of Pfizer Inc. Uniject is a trademark of BD.
      1Sayana Press and depo-subQ provera 104 in Uniject are registered trademarks of Pfizer Inc. Uniject is a trademark of BD.
      SP simplifies the injection process; it requires no assembly of components and is easily disposable. This new technology appears to be well suited for community-based delivery of injectable contraception. The study objective was to evaluate SP management and administration in low-resource settings, focusing on how the delivery logistics, administration time, storage and waste-management requirements compare to the traditional intramuscular DMPA injectable (DMPA IM).

      Study design

      We conducted 58 semistructured interviews with clinic providers and community health workers in Senegal and Uganda to identify the merits, challenges and appeal of SP relative to DMPA IM.


      Providers identified logistical challenges with the management and administration of DMPA IM, including stock outs, transportation, storage constraints, and, in a few instances, waste disposal. Most providers (between 63% and 88%, depending on the logistics issue) do not expect SP to either aggravate or solve those problems. Some envisioned that SP could facilitate supply management (5%), storage (11%) and waste disposal (22%). The all-in-one packaging of SP was perceived to reduce the incidence of mismatched supplies (syringes and vials), and its smaller size was expected to ease space constraints and reduce the frequency of safety box incineration.


      Adding SP to the method mix is unlikely to have a profound impact on clinic operations but may lessen logistical problems related to supply, storage and waste management.


      Community health workers and clinic providers who administer SP may see some modest improvements in service delivery logistics. Particularly in settings where service delivery logistical challenges are more pronounced, offering SP may facilitate injectable contraceptive delivery.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Contraception
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Ross J.A.
        • Agwanda A.T.
        Increased use of injectable contraception in sub-Saharan Africa.
        Afr J Reprod Health. 2012; 16: 68-80
      1. World Health Organization, US Agency for International Development, Family Health International (FHI). Community-based health workers can safely and effectively administer injectable contraceptives: conclusions from a technical consultation. Research Triangle Park (NC): FHI; 2009.

        • Burke H.
        • Mueller M.
        • Packer C.
        • Perry B.
        • Bufumbo L.
        • Mbengue D.
        • Daff B.M.
        • Mbonye A.
        Provider acceptability of Sayana® Press: results from community health workers and clinic-based providers in Uganda and Senegal.
        Contraception. 2014; 89: 368-373
        • Burke H.
        • Mueller M.
        • Perry B.
        • Packer C.
        • Bufumbo L.
        • Mbengue D.
        • Mall I.
        • Daff B.M.
        • Mbonye A.
        Observational study of the acceptability of Sayana® Press among intramuscular DMPA users in Uganda and Senegal.
        Contraception. 2014; 89: 361-367
        • Polis C.B.
        • Nakigozi G.F.
        • Nakawooya H.
        • Mondo G.
        • Makumbi F.
        • Nabwire M.
        • Sekasanvu J.
        • Lutalo T.
        • Kigozi G.
        • Nalugoda F.
        • Gray R.H.
        Preference for Sayana® Press versus intramuscular Depo-Provera among HIV-positive women in Rakai, Uganda: a randomized crossover trial.
        Contraception. 2014; 89: 385-395
        • Sutanto A.
        • Suarnawa I.M.
        • Nelson C.M.
        • Stewart T.
        • Soewarso T.I.
        Home delivery of heat-stable vaccines in Indonesia: outreach immunization with a prefilled, single-use injection device.
        Bull World Health Organ. 1999; 77: 119-126
        • Tsu V.D.
        • Sutanto A.
        • Vaidya K.
        • Coffey P.
        • Widjaya A.
        Oxytocin in prefilled Uniject™ injection devices for managing third-stage labor in Indonesia.
        Int J of Gynecol Obstet. 2003; 83: 103-111
        • Bahamondes L.
        • Marchi N.M.
        • de Lourdes Cristofoletti M.
        • Nakagava H.M.
        • Pellini E.
        • Araujo F.
        • Rubin J.
        Uniject™ as a delivery system for the once-a-month injectable contraceptive Cyclofem® in Brazil.
        Contraception. 1996; 53: 115-119
        • Uganda Bureau of Statistics (UBOS) and ICF International Inc. 2012. Uganda demographic and health survey
        Kampala, Uganda: UBOS and Calverton.
        ICF International Inc., Maryland2011
      2. FHI 360 community-based family planning — radical common sense: PROGRESS end of project meeting report. Protea Hotel, March 28, 2013.

      3. Agence Nationale de la Statistique et de la Démographie (ANSD). 2012. Enquête Démographique et de Santé Continue, 2012. Senegal.

      4. Ministère de la Santé et de l’action Sociale, Direction de la Santé, Division de la Santé de la Reproduction. Plan d ’action national de Planification Familiale 2012–2015.

        • Nersesian P.V.
        • Cesarz V.
        • Cochran A.
        • Mboyane J.
        • Schmidt K.
        Safe injection and waste management: a reference for logistics advisors.
        John Snow, Inc./DELIVER, for the US Agency for International Development, Arlington (VA)2004
      5. PATH. Introducing auto-disable syringes and sharps disposal containers with DMPA. Seattle (WA): PATH; July 19, 2001.